(Q24244050)

30 October 2023

Byungmook Lim

1

B

Lim

1 reference

30 October 2023

Eric Manheimer

2

E

Manheimer

1 reference

30 October 2023

Eric Ziea

4

E

Ziea

1 reference

30 October 2023

Julia Wisniewski

5

J

Wisniewski

1 reference

30 October 2023

Jianping Liu

6

J

Liu

1 reference

30 October 2023

Brian M Berman

7

B

Berman

1 reference

Cochrane Database of Systematic Reviews

30 October 2023

language of work or name

1 reference

18 October 2006

0 references

published in

0 references

cites work

Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Irritable bowel syndrome: a technical review for practice guideline development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Is acupuncture effective for the treatment of chronic pain? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

The economic consequences of irritable bowel syndrome: a US employer perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Acupuncture for patients with migraine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Producing and disseminating systematic reviews: a summary of the CAM-related work presented at the 13th international Cochrane Colloquium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Costs of irritable bowel syndrome in the UK and US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

A systematic review of alternative therapies in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Introducing a placebo needle into acupuncture research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

Predictors of health care seeking for irritable bowel syndrome: a population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

21 January 2018

Irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Acupuncture treatment for irritable bowel syndrome. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005111.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD005111.PUB2

0 references

Fatcat ID

release_6jspag5r3jfaflxpzl2624w4qy

0 references